Position in AMGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$5,978,239
+$116,067 QoQ
Shares Held
16,509
-0.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#750
of 3,140 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $121,333,460 across 13 Drug Manufacturers - General names. AMGN ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,412 | $36,477,068 | |
| 2 | JNJ |
Johnson & Johnson
|
113,666 | $28,867,754 | |
| 3 | ABBV |
AbbVie Inc.
|
73,916 | $18,600,222 | |
| 4 | MRK |
Merck & Co., Inc.
|
100,135 | $12,867,347 | |
| 5 | AMGN |
Amgen Inc
This page
|
16,509 | $5,978,239 | |
| 6 | PFE |
Pfizer Inc
|
235,737 | $5,676,546 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
30,495 | $3,852,738 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
59,835 | $3,447,692 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,978,239 | 16,509 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $5,862,172 | 16,661 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $5,495,207 | 16,789 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $6,545,911 | 23,196 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $6,701,877 | 24,003 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,600,271 | 11,556 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $4,235,660 | 16,251 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $5,082,540 | 15,774 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $4,472,096 | 14,313 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,734,021 | 9,616 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,715,452 | 9,428 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $748,496 | 2,785 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $553,495 | 2,493 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $819,774 | 3,391 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $885,622 | 3,372 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $799,719 | 3,548 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $769,071 | 3,161 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $883,126 | 3,652 | Shares | Sole | 2022-06-10 | |
| 2021-12-31 | $843,637 | 3,750 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $839,329 | 3,947 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $918,693 | 3,769 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $876,806 | 3,524 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $897,377 | 3,903 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,581,503 | 10,157 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||